ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Boston, MA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Non-Small-Cell Lung Carcinoma
Neoplasm Metastasis
Ovarian Cancer
Endometrial Cancer

Breast Cancer trials near Boston, MA, USA:

DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs

The purpose of this study is to test the safety and effectiveness of the study drug datopotamab deruxtecan in participants with metastatic breast...

Enrolling
Breast Cancer
Breast Cancer Female
Drug: Datopotamab Deruxtecan

Phase 2

Sarah Sammons, MD

Boston, Massachusetts, United States and 2 other locations

study drug, Nivolumab as a possible treatment for triple-negative breast cancer that has spread to other parts of the body.The inte...

Active, not recruiting
Breast Cancer
Drug: Carboplatin
Drug: Nivolumab

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Boston, Massachusetts, United States and 9 other locations

This research study is studying a combination of drugs as a possible treatment for breast cancer with a BRCA mutation.The intervent...

Active, not recruiting
Breast Cancer
Drug: Olaparib
Drug: Sapacitabine

Phase 1

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Boston, Massachusetts, United States and 1 other location

This research study involves pre-operative therapy that is specifically targeted for breast cancer in individuals with BRCA and PAL...

Active, not recruiting
Breast Cancer
Stage II Breast Cancer
Drug: Niraparib
Drug: Dostarlimab

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Boston, Massachusetts, United States and 7 other locations

This research study is studying Ruxolitinib as possible treatment for Inflammatory Breast Cancer (IBC).The Following drugs will be ...

Active, not recruiting
Inflammatory Breast Cancer (IBC)
Drug: Paclitaxel
Drug: Cyclophosphamide

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Boston, Massachusetts, United States and 3 other locations

Herceptin Hylecta, or trastuzumab biosimilar) in metastatic HER2+ breast cancer.The names of the study drugs used in this research ...

Enrolling
Breast Cancer Female
Breast Cancer Metastatic
Drug: Trastuzumab
Drug: Sacituzumab Govitecan

Phase 2

Adrienne G. Waks

Boston, Massachusetts, United States and 3 other locations

This research study is studying a drug called GDC-0084 as a possible treatment for HER2-Positive Breast Cancer.The drugs involved i...

Active, not recruiting
Breast Cancer
Drug: Trastuzumab
Drug: GDC-0084

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Boston, Massachusetts, United States

This research study is for patients with metastatic breast cancer.* Metastatic means that the cancer has spread beyond the ...

Active, not recruiting
Somatic Mutation Breast Cancer (BRCA1)
Somatic Mutation Breast Cancer (BRCA2)
Drug: Olaparib

Phase 2

Beth Israel Lahey Health
Beth Israel Lahey Health

Boston, Massachusetts, United States and 19 other locations

This research study is studying a drug as a possible treatment for ER-positive Breast CancerThe drug involved in this study is:-Rib...

Active, not recruiting
Breast Cancer
Drug: Ribociclib
Other: Endocrine therapy

Phase 2

Mass General Brigham
Mass General Brigham

Boston, Massachusetts, United States and 2 other locations

This research study is studying a drug combination of nivolumab and ipilimumab as a possible treatment for hypermutated HER2 negative breast ...

Active, not recruiting
Breast Cancer
Drug: Ipilimumab
Drug: Nivolumab

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Boston, Massachusetts, United States and 2 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems